Literature DB >> 17658266

Predictors of mortality after aortic valve replacement.

Yanto Sandy Tjang1, Yvonne van Hees, Reiner Körfer, Diederick E Grobbee, Geert J M G van der Heijden.   

Abstract

Aortic valve replacement (AVR) is recommended as a standard surgical procedure for aortic valve disease. Still the evidence for commonly claimed predictors of post-AVR prognosis, in particular mortality, appears scant. This systematic review reports on the evidence for predictors of post-AVR mortality, and may be helpful in pre-surgical risk-stratification. In PubMed, we searched for original reports of post-AVR follow-up studies. We assessed the quality of study design and methods with a standardized checklist. Data of the reported predictors of mortality and outcomes were extracted. Twenty-eight studies met our inclusion criteria. Sixteen studies were considered of high quality. There is strong evidence that the risk of early mortality is increased by emergency surgery, while the risk of late mortality is increased with older age and preoperative atrial fibrillation. There is moderate evidence that the risk of early mortality is increased by older age, aortic insufficiency, coronary artery disease, longer cardiopulmonary bypass time, reduced left ventricular ejection fraction (LV-EF), infective endocarditis, hypertension, mechanical valves, preoperative pacing, dialysis-dependent renal failure and valve size; and that the risk for late mortality is increased by emergency surgery and urgency of the operation. There is little evidence for high New York Heart Association class, concomitant coronary artery bypass graft and many other commonly claimed risk factors for post-AVR mortality. The reported evidence on predictors of post-AVR mortality will help for pre-surgical risk-stratification, i.e. to discern patients at high or low risk for early and late post-AVR mortality. Future prognostic studies should take the evidence from this review into account and should focus on derivation of a predictive model for post-AVR survival.

Entities:  

Mesh:

Year:  2007        PMID: 17658266     DOI: 10.1016/j.ejcts.2007.06.012

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  24 in total

1.  Impact of New York Heart Association classification, advanced age and patient-prosthesis mismatch on outcomes in aortic valve replacement surgery.

Authors:  Alex Zapolanski; Andrew W C Mak; Giovanni Ferrari; Christopher Johnson; Richard E Shaw; Mariano E Brizzio; Jason S Sperling; Juan B Grau
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-04

2.  EUROSCORE: still gold standard or less?

Authors:  Christoph Bode; Malte Kelm
Journal:  Clin Res Cardiol       Date:  2009-05-05       Impact factor: 5.460

3.  Adherence to surgical site infection guidelines in Italian cardiac surgery units.

Authors:  A Pan; L Ambrosini; A Patroni; L Soavi; L Signorini; G Carosi; C Santini
Journal:  Infection       Date:  2009-03-23       Impact factor: 3.553

4.  Multimarker Approach to Identify Patients With Higher Mortality and Rehospitalization Rate After Surgical Aortic Valve Replacement for Aortic Stenosis.

Authors:  Brian R Lindman; Marie-Annick Clavel; Rami Abu-Alhayja'a; Nancy Côté; François Dagenais; Eric Novak; Pierre Voisine; Anthony Poulin; Benoit J Arsenault; Philippe Desmeules; Abdellaziz Dahou; Lionel Taster; Khitam Aldahoun; Yohan Bossé; Patrick Mathieu; Philippe Pibarot
Journal:  JACC Cardiovasc Interv       Date:  2018-11-12       Impact factor: 11.195

5.  Predicting 30-day mortality of aortic valve replacement by the AVR score.

Authors:  B M Swinkels; F E E Vermeulen; J C Kelder; W J van Boven; H W M Plokker; J M Ten Berg
Journal:  Neth Heart J       Date:  2011-06       Impact factor: 2.380

Review 6.  Wireless and battery-free platforms for collection of biosignals.

Authors:  Tucker Stuart; Le Cai; Alex Burton; Philipp Gutruf
Journal:  Biosens Bioelectron       Date:  2021-01-23       Impact factor: 10.618

7.  Aortic valve replacement in young patients: should the biological prosthesis be recommended over the mechanical?

Authors:  Alberto Alperi; Daniel Hernandez-Vaquero; Isaac Pascual; Rocio Diaz; Iria Silva; Ruben Alvarez-Cabo; Pablo Avanzas; Cesar Moris
Journal:  Ann Transl Med       Date:  2018-05

Review 8.  Timing and Outcomes of PCI in the TAVR Era.

Authors:  Konstantinos V Voudris; Peter Petropulos; Panagiotis Karyofillis; Konstantinos Charitakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-06

Review 9.  Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI.

Authors:  Edward Danson; Peter Hansen; Sayan Sen; Justin Davies; Ian Meredith; Ravinay Bhindi
Journal:  Nat Rev Cardiol       Date:  2016-02-11       Impact factor: 32.419

10.  Coronary artery disease and outcomes of aortic valve replacement for severe aortic stenosis.

Authors:  Jocelyn M Beach; Tomislav Mihaljevic; Lars G Svensson; Jeevanantham Rajeswaran; Thomas Marwick; Brian Griffin; Douglas R Johnston; Joseph F Sabik; Eugene H Blackstone
Journal:  J Am Coll Cardiol       Date:  2013-02-26       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.